GlassScriptPhysician profile
Maahum A Haider
NPI 1902121254
$2,920.78
in general payments reported to CMS, 2019-2025
26 companies · $1,991 in 2025
The $1,991 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.28 · 2022: $65.70 · 2023: $47.10 · 2024: $778 · 2025: $1,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Travel and Lodging: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.15 |
| Travel and Lodging | $832.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $892.49 | 2025 | |
| Boston Scientific Corporation | $197.47 | 2021-2025 | Rezum Generator, Lithovue |
| Progenics Pharmaceuticals, INC. | $171.00 | 2024-2025 | |
| Janssen Biotech, INC. | $168.25 | 2025 | Erleada |
| Valencia Technologies Corporation | $166.27 | 2025 | Ecoin Device Kit |
| Calyxo, INC. | $162.68 | 2025 | Cvac Aspiration System |
| Dornier Medtech America, INC | $138.51 | 2025 | Dornier Medtech |
| Astellas Pharma Global Development | $131.61 | 2024 | Xtandi |
| Innovation Technologies INC | $115.14 | 2024 | Irrisept |
| Janssen Scientific Affairs, LLC | $112.26 | 2025 | |
| Ferring Pharmaceuticals INC. | $95.16 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $88.70 | 2024-2025 | |
| Coloplast Corp | $71.60 | 2024 | |
| Baxter Healthcare | $53.36 | 2024 | Tisseel |
| Antares Pharma, INC. | $51.83 | 2024-2025 | Xyosted |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $36.54 | 2024 | |
| Telix Pharmaceuticals | $36.40 | 2024 | Illuccix |
| Astrazeneca Pharmaceuticals LP | $33.98 | 2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $33.48 | 2025 | Provenge |
| Sumitomo Pharma America, INC. | $31.69 | 2025 | Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $27.84 | 2024 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $26.37 | 2025 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $20.99 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $20.87 | 2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $18.52 | 2024 | Keytruda |
| Pfizer INC. | $17.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maahum Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.